SE508760C2 - Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur - Google Patents

Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur

Info

Publication number: SE508760C2
Authority: SE; Sweden
Prior art keywords: chitosan; polysaccharide; use according; composition; nnn
Prior art date: 1997-04-29

Application number

SE9701616A

Other languages

English (en)

Swedish (sv)

Other versions

SE9701616L (sv

SE9701616D0 (sv

Inventor

Olle Larm

Marcus Back

Original Assignee

Medicarb Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-29

Filing date

1997-04-29

Publication date

1998-11-02

1997-04-29 Application filed by Medicarb Ab filed Critical Medicarb Ab

1997-04-29 Priority to SE9701616A priority Critical patent/SE508760C2/sv

1997-04-29 Publication of SE9701616D0 publication Critical patent/SE9701616D0/xx

1998-04-28 Priority to CN98800555A priority patent/CN1225555A/zh

1998-04-28 Priority to DE69807818T priority patent/DE69807818T2/de

1998-04-28 Priority to AT98920795T priority patent/ATE223649T1/de

1998-04-28 Priority to US09/202,930 priority patent/US6630458B2/en

1998-04-28 Priority to ES98920795T priority patent/ES2183359T3/es

1998-04-28 Priority to NZ333511A priority patent/NZ333511A/en

1998-04-28 Priority to EP98920795A priority patent/EP0917427B1/de

1998-04-28 Priority to PCT/SE1998/000776 priority patent/WO1998048627A1/en

1998-04-28 Priority to CA002259327A priority patent/CA2259327A1/en

1998-04-28 Priority to DK98920795T priority patent/DK0917427T3/da

1998-04-28 Priority to HU0000754A priority patent/HUP0000754A3/hu

1998-04-28 Priority to PL98330870A priority patent/PL330870A1/xx

1998-04-28 Priority to BR9804875-9A priority patent/BR9804875A/pt

1998-04-28 Priority to JP10546900A priority patent/JP2000515897A/ja

1998-04-28 Priority to AU73548/98A priority patent/AU721692B2/en

1998-10-30 Publication of SE9701616L publication Critical patent/SE9701616L/xx

1998-11-02 Publication of SE508760C2 publication Critical patent/SE508760C2/sv

1998-12-23 Priority to BG103034A priority patent/BG64027B1/bg

Links

239000000203 mixture Substances 0.000 title claims abstract description 41
229920001661 Chitosan Polymers 0.000 title claims abstract description 33
150000004676 glycans Chemical class 0.000 title claims abstract description 27
229920001282 polysaccharide Polymers 0.000 title claims abstract description 27
239000005017 polysaccharide Substances 0.000 title claims abstract description 27
238000007598 dipping method Methods 0.000 title claims abstract description 19
241001465754 Metazoa Species 0.000 title claims abstract description 18
239000002904 solvent Substances 0.000 title claims abstract description 10
235000013336 milk Nutrition 0.000 title claims description 18
239000008267 milk Substances 0.000 title claims description 18
210000004080 milk Anatomy 0.000 title claims description 18
239000003795 chemical substances by application Substances 0.000 title claims description 13
238000002360 preparation method Methods 0.000 title claims description 12
235000013365 dairy product Nutrition 0.000 title description 3
241000283690 Bos taurus Species 0.000 claims abstract description 41
208000004396 mastitis Diseases 0.000 claims abstract description 16
229920002307 Dextran Polymers 0.000 claims abstract description 8
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims abstract description 7
229910021653 sulphate ion Inorganic materials 0.000 claims abstract description 7
230000000069 prophylactic effect Effects 0.000 claims abstract description 6
229920002971 Heparan sulfate Polymers 0.000 claims abstract description 4
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims abstract description 4
229920000669 heparin Polymers 0.000 claims abstract description 4
229960002897 heparin Drugs 0.000 claims abstract description 4
230000029663 wound healing Effects 0.000 claims abstract 2
230000001580 bacterial effect Effects 0.000 claims description 23
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 21
230000000694 effects Effects 0.000 claims description 15
239000002019 doping agent Substances 0.000 claims description 8
229920000609 methyl cellulose Polymers 0.000 claims description 7
239000001923 methylcellulose Substances 0.000 claims description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
238000006640 acetylation reaction Methods 0.000 claims description 5
230000004888 barrier function Effects 0.000 claims description 5
230000001105 regulatory effect Effects 0.000 claims description 5
230000009471 action Effects 0.000 claims description 4
230000003385 bacteriostatic effect Effects 0.000 claims description 4
238000005507 spraying Methods 0.000 claims description 4
229920002678 cellulose Polymers 0.000 claims description 3
239000001913 cellulose Substances 0.000 claims description 3
239000004480 active ingredient Substances 0.000 claims description 2
238000000034 method Methods 0.000 abstract description 6
238000004519 manufacturing process Methods 0.000 abstract description 2
230000008569 process Effects 0.000 abstract description 2
210000000481 breast Anatomy 0.000 description 49
210000002445 nipple Anatomy 0.000 description 42
239000000243 solution Substances 0.000 description 26
238000002474 experimental method Methods 0.000 description 15
229920001817 Agar Polymers 0.000 description 13
239000008272 agar Substances 0.000 description 13
102000011782 Keratins Human genes 0.000 description 12
108010076876 Keratins Proteins 0.000 description 12
229960000633 dextran sulfate Drugs 0.000 description 12
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 10
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
229910052740 iodine Inorganic materials 0.000 description 10
239000011630 iodine Substances 0.000 description 10
208000015181 infectious disease Diseases 0.000 description 8
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
235000010981 methylcellulose Nutrition 0.000 description 6
241000894006 Bacteria Species 0.000 description 5
238000004458 analytical method Methods 0.000 description 5
229960002086 dextran Drugs 0.000 description 5
244000144980 herd Species 0.000 description 5
GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 4
241000193985 Streptococcus agalactiae Species 0.000 description 4
229960003260 chlorhexidine Drugs 0.000 description 4
230000006651 lactation Effects 0.000 description 4
238000012360 testing method Methods 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
229920002101 Chitin Polymers 0.000 description 3
206010052428 Wound Diseases 0.000 description 3
208000027418 Wounds and injury Diseases 0.000 description 3
230000008901 benefit Effects 0.000 description 3
230000035876 healing Effects 0.000 description 3
239000000463 material Substances 0.000 description 3
239000011734 sodium Substances 0.000 description 3
239000000725 suspension Substances 0.000 description 3
241000588724 Escherichia coli Species 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
239000000654 additive Substances 0.000 description 2
239000003513 alkali Substances 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
239000012141 concentrate Substances 0.000 description 2
238000003381 deacetylation reaction Methods 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
230000001717 pathogenic effect Effects 0.000 description 2
238000012545 processing Methods 0.000 description 2
241000894007 species Species 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
239000008107 starch Substances 0.000 description 2
239000008223 sterile water Substances 0.000 description 2
239000002699 waste material Substances 0.000 description 2
NBRQRXRBIHVLGI-OWXODZSWSA-N (4as,5ar,12ar)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=CC=CC(O)=C2C(O)=C(C2=O)[C@@H]1C[C@@H]1[C@@]2(O)C(O)=C(C(=O)N)C(=O)C1 NBRQRXRBIHVLGI-OWXODZSWSA-N 0.000 description 1
PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
229920002558 Curdlan Polymers 0.000 description 1
239000001879 Curdlan Substances 0.000 description 1
241000238557 Decapoda Species 0.000 description 1
-1 Dextran sulfate Chemical compound 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
239000001856 Ethyl cellulose Substances 0.000 description 1
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
229920002581 Glucomannan Polymers 0.000 description 1
229920002907 Guar gum Polymers 0.000 description 1
229920002488 Hemicellulose Polymers 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
229920001612 Hydroxyethyl starch Polymers 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
229920000161 Locust bean gum Polymers 0.000 description 1
229920000881 Modified starch Polymers 0.000 description 1
230000006181 N-acylation Effects 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
239000004373 Pullulan Substances 0.000 description 1
229920001218 Pullulan Polymers 0.000 description 1
206010072170 Skin wound Diseases 0.000 description 1
241000295644 Staphylococcaceae Species 0.000 description 1
244000269722 Thea sinensis Species 0.000 description 1
208000025865 Ulcer Diseases 0.000 description 1
125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
229920000617 arabinoxylan Polymers 0.000 description 1
244000052616 bacterial pathogen Species 0.000 description 1
230000000721 bacterilogical effect Effects 0.000 description 1
MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical group N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
229920001222 biopolymer Polymers 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000006161 blood agar Substances 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
238000011109 contamination Methods 0.000 description 1
239000006071 cream Substances 0.000 description 1
235000019316 curdlan Nutrition 0.000 description 1
229940078035 curdlan Drugs 0.000 description 1
230000018044 dehydration Effects 0.000 description 1
238000006297 dehydration reaction Methods 0.000 description 1
238000013461 design Methods 0.000 description 1
XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
229940093496 esculin Drugs 0.000 description 1
AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
229920001249 ethyl cellulose Polymers 0.000 description 1
235000019325 ethyl cellulose Nutrition 0.000 description 1
239000004459 forage Substances 0.000 description 1
239000010437 gem Substances 0.000 description 1
239000004461 grass silage Substances 0.000 description 1
230000009422 growth inhibiting effect Effects 0.000 description 1
239000000665 guar gum Substances 0.000 description 1
235000010417 guar gum Nutrition 0.000 description 1
229960002154 guar gum Drugs 0.000 description 1
239000004463 hay Substances 0.000 description 1
235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
229940050526 hydroxyethylstarch Drugs 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
239000000711 locust bean gum Substances 0.000 description 1
235000010420 locust bean gum Nutrition 0.000 description 1
230000007774 longterm Effects 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
235000019426 modified starch Nutrition 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000000149 penetrating effect Effects 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
235000019423 pullulan Nutrition 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
235000015170 shellfish Nutrition 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000011550 stock solution Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
230000008961 swelling Effects 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
230000007704 transition Effects 0.000 description 1
239000001974 tryptic soy broth Substances 0.000 description 1
108010050327 trypticase-soy broth Proteins 0.000 description 1
239000012137 tryptone Substances 0.000 description 1
231100000397 ulcer Toxicity 0.000 description 1
239000012224 working solution Substances 0.000 description 1
229920001285 xanthan gum Polymers 0.000 description 1
239000000230 xanthan gum Substances 0.000 description 1
235000010493 xanthan gum Nutrition 0.000 description 1
229940082509 xanthan gum Drugs 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
- A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Wood Science & Technology (AREA)
Pest Control & Pesticides (AREA)
Plant Pathology (AREA)
Engineering & Computer Science (AREA)
Dentistry (AREA)
Agronomy & Crop Science (AREA)
Zoology (AREA)
Environmental Sciences (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
Lubricants (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Glass Compositions (AREA)
Manufacturing Of Micro-Capsules (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

SE9701616A 1997-04-29 1997-04-29 Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur SE508760C2 (sv)

Priority Applications (17)

Application Number	Priority Date	Filing Date	Title
SE9701616A SE508760C2 (sv)	1997-04-29	1997-04-29	Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur
AU73548/98A AU721692B2 (en)	1997-04-29	1998-04-28	Teat dipping agent
PCT/SE1998/000776 WO1998048627A1 (en)	1997-04-29	1998-04-28	Teat dipping agent
DK98920795T DK0917427T3 (da)	1997-04-29	1998-04-28	Pattedypningsmiddel
AT98920795T ATE223649T1 (de)	1997-04-29	1998-04-28	Mittel zum eintauchen von zitzen
US09/202,930 US6630458B2 (en)	1997-04-29	1998-04-28	Teat dipping agent
ES98920795T ES2183359T3 (es)	1997-04-29	1998-04-28	Agente desinfectante de pezones por inmersion.
NZ333511A NZ333511A (en)	1997-04-29	1998-04-28	Teat dipping agent comprising chitosan and a polysaccharide
EP98920795A EP0917427B1 (de)	1997-04-29	1998-04-28	Mittel zum eintauchen von zitzen
CN98800555A CN1225555A (zh)	1997-04-29	1998-04-28	乳头浸洗剂
CA002259327A CA2259327A1 (en)	1997-04-29	1998-04-28	Teat dipping agent
DE69807818T DE69807818T2 (de)	1997-04-29	1998-04-28	Mittel zum eintauchen von zitzen
HU0000754A HUP0000754A3 (en)	1997-04-29	1998-04-28	Teat dipping agent
PL98330870A PL330870A1 (en)	1997-04-29	1998-04-28	Teats soaking agent
BR9804875-9A BR9804875A (pt)	1997-04-29	1998-04-28	Uso de uma composição e peocesso para tratamento profilático ou de cicatrização de feridas de animais de lactação.
JP10546900A JP2000515897A (ja)	1997-04-29	1998-04-28	乳頭浸漬剤
BG103034A BG64027B1 (bg)	1997-04-29	1998-12-23	Средство за потапяне на бозки

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9701616A SE508760C2 (sv)	1997-04-29	1997-04-29	Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur

Publications (3)

Publication Number	Publication Date
SE9701616D0 SE9701616D0 (sv)	1997-04-29
SE9701616L SE9701616L (sv)	1998-10-30
SE508760C2 true SE508760C2 (sv)	1998-11-02

Family

ID=20406772

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE9701616A SE508760C2 (sv)	1997-04-29	1997-04-29	Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur

Country Status (17)

Country	Link
US (1)	US6630458B2 (de)
EP (1)	EP0917427B1 (de)
JP (1)	JP2000515897A (de)
CN (1)	CN1225555A (de)
AT (1)	ATE223649T1 (de)
AU (1)	AU721692B2 (de)
BG (1)	BG64027B1 (de)
BR (1)	BR9804875A (de)
CA (1)	CA2259327A1 (de)
DE (1)	DE69807818T2 (de)
DK (1)	DK0917427T3 (de)
ES (1)	ES2183359T3 (de)
HU (1)	HUP0000754A3 (de)
NZ (1)	NZ333511A (de)
PL (1)	PL330870A1 (de)
SE (1)	SE508760C2 (de)
WO (1)	WO1998048627A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7968122B2 (en)	2003-12-10	2011-06-28	Adventrx Pharmaceuticals, Inc.	Anti-viral pharmaceutical compositions

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPP659198A0 (en) *	1998-10-19	1998-11-12	Novogen Research Pty Ltd	Mastitis treatment
US20020119949A1 (en) *	2001-02-26	2002-08-29	Asa Hellman	Prophylactic teat treatment
WO2002083104A1 (en) *	2001-04-12	2002-10-24	Medicarb Ab	An effervescent solid composition of matter
SE522529C2 (sv)	2001-04-12	2004-02-17	Medicarb Ab	Effervescent fastämneskomposition innefattande som aktiv komponent kitosan, dess derivat och salter därav, användning samt framställning därav
EP1455835A2 (de) *	2001-12-13	2004-09-15	ISM Biopolymer Inc.	Verfahren zur modulation der saccharidfreisetzung und deren verwendung
DE60229431D1 (de) *	2001-12-14	2008-11-27	Dnp Canada Inc	Verwendungen von chitosanoligosacchariden
US20040180015A1 (en) *	2002-01-07	2004-09-16	Kross Robert D.	Long-acting disinfecting nitrous acid compositions and related processes
US8778369B2 (en) *	2005-07-29	2014-07-15	Delaval Holding Ab	Barrier film-forming compositions and methods of use
US20070142322A1 (en) *	2005-12-20	2007-06-21	Kaspar Charles W	Method of using chitosan to reduce shedding of E. coli from bovines
NZ549249A (en)	2006-08-18	2009-10-30	Univ Massey	Methods for reducing the incidence of mastitis by administration of keratin
WO2010088191A1 (en) *	2009-01-27	2010-08-05	Teleflex Medical Incorporated	Sputum dissolving suctioning solution for endotracheal and tracheostomy tubes
CA2790682C (en)	2010-03-03	2020-11-24	Neocutis Sa	Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
US8757092B2 (en)	2011-03-22	2014-06-24	Eco-Composites Llc	Animal bedding and associated method for preparing the same
US9737047B2 (en)	2011-03-22	2017-08-22	Ccd Holdings Llc	Method for the treatment, control, minimization, and prevention of bovine mastitis
WO2016040873A1 (en) *	2014-09-12	2016-03-17	Ccd Holdings Llc	Method for the treatment, control, minimization, and prevention of bovine mastitis
CN104430395B (zh) *	2014-10-30	2016-08-24	青岛青知企业管理咨询有限公司	一种用于防治甘蓝小菜蛾的复配乳油

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0285357A3 (de) *	1987-03-31	1989-10-25	Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo	Bekämpfung von Retroviren
JP3205104B2 (ja)	1992-01-20	2001-09-04	川研ファインケミカル株式会社	化粧料
RU2048473C1 (ru)	1992-12-25	1995-11-20	Гамзазаде Ариф Исмаилович	Способ получения интерполимерных комплексов хитозана с декстрансульфатом натрия
SE9300139L (sv)	1993-01-19	1994-07-20	Medicarb Ab	Framställning av ett nytt läkemedel
SE518597C2 (sv) *	1994-05-04	2002-10-29	Medicarb Ab	Användning av kitosan i kombination med en sulfaterad, negativt laddad polysackarid för framställning av en dentalt verksam munhygienkomposition för behandling av parodontit, plaques och/eller karies
SE9402531L (sv) *	1994-07-19	1996-01-20	Medicarb Ab	Sårläkningsmedel
SE507028C2 (sv)	1996-08-06	1998-03-16	Medicarb Ab	Ny medicinsk användning

1997
- 1997-04-29 SE SE9701616A patent/SE508760C2/sv not_active IP Right Cessation
1998
- 1998-04-28 CA CA002259327A patent/CA2259327A1/en not_active Abandoned
- 1998-04-28 PL PL98330870A patent/PL330870A1/xx unknown
- 1998-04-28 DE DE69807818T patent/DE69807818T2/de not_active Expired - Fee Related
- 1998-04-28 ES ES98920795T patent/ES2183359T3/es not_active Expired - Lifetime
- 1998-04-28 HU HU0000754A patent/HUP0000754A3/hu unknown
- 1998-04-28 WO PCT/SE1998/000776 patent/WO1998048627A1/en not_active Ceased
- 1998-04-28 BR BR9804875-9A patent/BR9804875A/pt not_active Application Discontinuation
- 1998-04-28 EP EP98920795A patent/EP0917427B1/de not_active Expired - Lifetime
- 1998-04-28 US US09/202,930 patent/US6630458B2/en not_active Expired - Fee Related
- 1998-04-28 CN CN98800555A patent/CN1225555A/zh active Pending
- 1998-04-28 JP JP10546900A patent/JP2000515897A/ja not_active Ceased
- 1998-04-28 AT AT98920795T patent/ATE223649T1/de not_active IP Right Cessation
- 1998-04-28 DK DK98920795T patent/DK0917427T3/da active
- 1998-04-28 AU AU73548/98A patent/AU721692B2/en not_active Ceased
- 1998-04-28 NZ NZ333511A patent/NZ333511A/en unknown
- 1998-12-23 BG BG103034A patent/BG64027B1/bg unknown

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7968122B2 (en)	2003-12-10	2011-06-28	Adventrx Pharmaceuticals, Inc.	Anti-viral pharmaceutical compositions
US8470346B2 (en)	2003-12-10	2013-06-25	Mast Therapeutics, Inc.	Anti-viral pharmaceutical compositions

Also Published As

Publication number	Publication date
CA2259327A1 (en)	1998-11-05
BG103034A (en)	1999-10-29
CN1225555A (zh)	1999-08-11
BR9804875A (pt)	2000-01-25
PL330870A1 (en)	1999-06-07
US20020103159A1 (en)	2002-08-01
US6630458B2 (en)	2003-10-07
HUP0000754A3 (en)	2000-11-28
DK0917427T3 (da)	2002-10-07
DE69807818D1 (de)	2002-10-17
BG64027B1 (bg)	2003-11-28
EP0917427B1 (de)	2002-09-11
WO1998048627A1 (en)	1998-11-05
HUP0000754A2 (en)	2000-07-28
AU7354898A (en)	1998-11-24
JP2000515897A (ja)	2000-11-28
SE9701616L (sv)	1998-10-30
ES2183359T3 (es)	2003-03-16
NZ333511A (en)	2000-06-23
ATE223649T1 (de)	2002-09-15
SE9701616D0 (sv)	1997-04-29
AU721692B2 (en)	2000-07-13
DE69807818T2 (de)	2003-01-16
EP0917427A1 (de)	1999-05-26

Legal Events

Date	Code	Title	Description
2013-12-03	NUG	Patent has lapsed

Publication	Publication Date	Title
SE508760C2 (sv)	1998-11-02	Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur
EP0528697A1 (de)	1993-02-24	Sporizide, desinfizierende Zusammensetzungen, Herstellung und Verwendung
Erskine et al.	1995	Ceftiofur distribution in serum and milk from clinically normal cows and cows with experimental Escherichia coli-induced mastitis
JP2020183396A (ja)	2020-11-12	有機物質の存在下で改善された安定性を有するヨードフォア組成物
EP0017639A1 (de)	1980-10-15	Euter-Desinfektionsmittel und Verfahren der Zitzendesinfektion
GB2193078A (en)	1988-02-03	Hay preservative
Takahashi et al.	2004	Effect of intramammary injection of rboGM-CSF on milk levels of chemiluminescence activity, somatic cell count, and Staphylococcus aureus count in Holstein cows with S. aureus subclinical mastitis
CN112062904B (zh)	2022-03-29	一种京尼平交联抗菌肽/季铵化纤维素复合水凝胶抑菌剂及其制备方法与应用
CN114521566A (zh)	2022-05-24	一种防治芋软腐病的增效组合物
WO1995020968A1 (en)	1995-08-10	Prophylatic for domestic animal mastitis
JP2648886B2 (ja)	1997-09-03	家蓄の乳房炎を予防する方法
EP0473395A1 (de)	1992-03-04	Verwendung von Rhamsan gum zur Herstellung eines Arzneimittels zur Zitzenbehandlung
US20020119949A1 (en)	2002-08-29	Prophylactic teat treatment
KR100424339B1 (ko)	2004-03-24	키토산 처리된 건어물과 그 제조방법
Langlands	1971	Wool production of grazing sheep supplemented with casein and formaldehyde-treated casein
AU2002233873A1 (en)	2003-03-06	Prophylactic teat treatment
Alami et al.	2016	Industry Pharmaceuticals: Chitosan as an alternative replacement gelatin capsules on shell
JP3781733B2 (ja)	2006-05-31	キトサンを含む植物の耐病性及び成長を向上する組成物
CN115785482B (zh)	2024-06-07	一种水杨酸纤维素凝胶的制备方法及其产品和应用
Holmberg et al.	1983	A case of aflatoxicosis in fattening calves caused by aflatoxin formation in inadequate formic acid treated grain
CN117256616B (zh)	2025-08-12	一种防治烟草赤星病的农药组合物
JPH07258007A (ja)	1995-10-09	糖類誘導体を有効成分とする植物病害防除剤
CN115812742B (zh)	2026-01-30	含有溶菌酶和透明质酸锌的抑菌组合物及其应用
CN102961331A (zh)	2013-03-13	一种壳聚糖碘溶液配方及其制备方法
CN117530883A (zh)	2024-02-09	一种海洋多糖免洗手抑菌凝胶及制备方法